Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients

Authors not listed

Siriraj Hospital · 2023

Stem-cell exhaustion Chronic inflammation Stem-cell therapy Human Randomized controlled trial

Abstract

Amniotic fluid mesenchymal stem cells developed for chondrogenic treatment (AFCC) are used to treat elderly patients suffering from knee osteoarthritis (OA). The injection reduces inflammation and promotes the recovery of knee function, leading to an improved quality of life.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2023). A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients. <em>Siriraj Hospital</em>. https://clinicaltrials.gov/study/NCT06386679

Vancouver

Anonymous. A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients. Siriraj Hospital. 2023.

BibTeX

@misc{anon2023APilot, title = {A Pilot Study: Safety and Efficacy of Allogenic Mesenchymal Stem Cell Type AFCC for Treating in Elderly Knee Osteoarthritis Patients}, author = {Anonymous}, journal = {Siriraj Hospital}, year = {2023}, }